Os oligonucleotídeos antisense são a primeira terapia génica (na realidade terapia de RNA antissentido, uma vez que não modificam o código genético) disponível no mercado para o tratamento de doenças neurogenéticas. Baseiam-se na técnica do salto do exon (Duchenne) ou da inclusão do éxon (AME). Em breve também estará disponível o tratamento para a distrofia miotônica de Steinert.

Esquema de los mecanismos de acción de los oligonucleótidos antisentido mediante el cambio de empalme. Se ilustra la inclusión del exón 7 en la atrofia muscular espinal y el salto del exón 51 en la distrofia muscular de Duchenne.
Figura 1. Esquema de los mecanismos de acción de los oligonucleótidos antisentido mediante el cambio de empalme. Se ilustra la inclusión del exón 7 en la atrofia muscular espinal y el salto del exón 51 en la distrofia muscular de Duchenne.
19955111 {19955111:JMSPQW4N} 1 vancouver 50 default 3561 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JMSPQW4N%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Daguenet%20et%20al.%22%2C%22parsedDate%22%3A%222015-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BDaguenet%20E%2C%20Dujardin%20G%2C%20Valc%26%23xE1%3Brcel%20J.%20The%20pathogenicity%20of%20splicing%20defects%3A%20mechanistic%20insights%20into%20pre-mRNA%20processing%20inform%20novel%20therapeutic%20approaches.%20EMBO%20reports%20%5BInternet%5D.%202015%20Dec%20%5Bcited%202022%20Nov%203%5D%3B16%2812%29%3A1640%26%23x2013%3B55.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembr.201541116%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembr.201541116%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20pathogenicity%20of%20splicing%20defects%3A%20mechanistic%20insights%20into%20pre-mRNA%20processing%20inform%20novel%20therapeutic%20approaches%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Daguenet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwendal%22%2C%22lastName%22%3A%22Dujardin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Valc%5Cu00e1rcel%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20Removal%20of%20introns%20from%20pre-mRNA%20precursors%20%28pre-mRNA%20splicing%29%20is%20a%20necessary%20step%20for%20the%20expression%20of%20most%20genes%20in%20multicellular%20organisms%2C%20and%20alternative%20patterns%20of%20intron%20removal%20diversify%20and%20regulate%20the%20output%20of%20genomic%20information.%20Mutation%20or%20natural%20variation%20in%20pre-mRNA%20sequences%2C%20as%20well%20as%20in%20spliceosomal%20components%20and%20regulatory%20factors%2C%20has%20been%20implicated%20in%20the%20etiology%20and%20progression%20of%20numerous%20pathologies.%20These%20range%20from%20monogenic%20to%20multifactorial%20genetic%20diseases%2C%20including%20metabolic%20syndromes%2C%20muscular%20dystrophies%2C%20neurodegenerative%20and%20cardiovascular%20diseases%2C%20and%20cancer.%20Understanding%20the%20molecular%20mechanisms%20associated%20with%20splicing-related%20pathologies%20can%20provide%20key%20insights%20into%20the%20normal%20function%20and%20physiological%20context%20of%20the%20complex%20splicing%20machinery%20and%20establish%20sound%20basis%20for%20novel%20therapeutic%20approaches.%22%2C%22date%22%3A%222015-12%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.15252%5C%2Fembr.201541116%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembr.201541116%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221469-221X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%228PUZ7DEQ%22%2C%22RUSQH6B4%22%5D%2C%22dateModified%22%3A%222026-10-27T22%3A56%3A49Z%22%7D%7D%5D%7D
1.
Daguenet E, Dujardin G, Valcárcel J. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO reports [Internet]. 2015 Dec [cited 2022 Nov 3];16(12):1640–55. Available from: https://www.embopress.org/doi/full/10.15252/embr.201541116